biotech-investing BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 10 December 2025
biotech-investing BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout 09 December 2025
biotech-investing BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 02 December 2025
